Cigna Health Expected to Post Higher 4Q Profit, Revenue -- Earnings Preview

Dow Jones
02/05

By Connor Hart

 

Cigna Group is scheduled to report fourth-quarter results before the market opens Thursday. Here is what you need to know.

NET INCOME: The healthcare company is projected to post a profit of $1.74 billion, up from $1.42 billion a year earlier, according to analysts polled by FactSet.

ADJUSTED EARNINGS: Stripping out one-time items, earnings are expected to come in at $7.88 a share. That compares with adjusted earnings of $6.64 a share a year ago.

REVENUE: Quarterly revenue is forecast to be $70.31 billion, up from the $65.68 billion it notched last year.

Shares have climbed 7.1% over the past three months and were recently trading hands at $275.54.

WHAT TO WATCH

--While it has since pared back some of the loss, Cigna's stock dropped last quarter after the company warned the profits for its pharmacy-benefits business would likely be squeezed in 2026. The company attributed the pressure largely to renegotiated contracts with three major clients and costs associated with adopting an ambitious new payment model. Investors will be looking to see if these pressures have started to weigh on the unit's bottom line.

--The Trump administration last month proposed roughly flat rates for Medicare insurers next year, an update that fell well short of Wall Street expectations and triggered a brief selloff among healthcare stocks. The Medicare agency is also proposing to eliminate a lucrative industry billing practice that has raised concerns with government watchdogs. Investors will be eager to see if the company addresses these proposals, and the impact they could have on business.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

February 04, 2026 13:25 ET (18:25 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10